Scientist have developed a method to turn cells from patients into mutation-free stem cells that can treat genetic diseases for which there is currently no cure.
"Right now, there are no cures for mitochondrial diseases," said senior author Juan Carlos Izpisua Belmonte, professor at Salk Institute for Biological Studies in California, US.
Mitochondrial diseases are caused by any of 200 mutations that affect the genes of mitochondria, tiny powerhouses inside nearly every cell of the body.
Depending on the affected genes and cell types, the diseases can cause muscle weakness, liver disease, diabetes, seizures, developmental delays or vision problems.
Existing therapies aim to ease the symptoms or slow the progression of the diseases, but cannot entirely cure them.
"We have developed ways to prevent these diseases, so it was natural to next ask how we could treat them," Belmonte said.
The researchers collected skin samples from patients with mitochondrial encephalomyopathy or Leigh Syndrome, both severe disorders that affect the brain and muscles.
In the study published in the journal Nature, the researchers described a method to generate stem cells even from patients who do not have cells with enough -- or any -- healthy mitochondria to start with.
For now, the researchers can use the healthy cells to generate heart, brain, muscle or eye cells from the mutation-free stem cells.
But methods to make those cells fully mature and functional and transplant them into patients are still under development, the study said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
